• Je něco špatně v tomto záznamu ?

Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic

O. Májek, J. Dušková, V. Dvořák, A. Beková, D. Klimeš, M. Blaha, A. Anttila, L. Dušek,

. 2017 ; 26 (3) : 232-239.

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18011287

In 2008, the organized Czech National Cervical Cancer Screening Programme (CNCCSP) was initiated by transformation of the existing opportunistic efforts. The aim of our study was to examine recent cervical cancer burden trends and to assess the quality of the Czech National Cervical Cancer Screening Programme using a set of standard performance indicators. Our study utilized data from the national Cervical Cancer Screening Registry and the Czech National Cancer Registry. We computed internationally accepted indicators and assessed time trends and variability among screening centres. Between 1995 and 2011, the incidence of age-standardized cervical cancer decreased by 21% (1023 cases in 2011), and the mortality decreased by 35% (399 deaths in 2011). The annual coverage of the target population by cervical screening increased to 56% in 2013 (as compared with 35% in 2001). If we consider a 2-year interval (2012-2013), the estimated coverage was 77%. Over two million women underwent screening in 2013; 96% of them had a negative result. About 0.2% of smears showed cytological signs of a high-grade intraepithelial lesion or a malignancy, and the estimated positive predictive value for advanced intraepithelial neoplasia (cervical intraepithelial neoplasia grade 2+) was 79.6%. However, performance indicators show considerable heterogeneity between screening centres. The reported values of performance indicators are in line with the results of programmes that have previously been shown to be successful in terms of decreasing the cervical cancer burden, and are promising with respect to an even more pronounced decrease in cervical cancer mortality in the near future, provided that continuous quality improvement can be maintained. Linkage studies between screening, cancer and cause-of-death registers can provide further information on screening effectiveness and validity issues.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18011287
003      
CZ-PrNML
005      
20240828141804.0
007      
ta
008      
180404s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1097/CEJ.0000000000000236 $2 doi
035    __
$a (PubMed)26908155
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Májek, Ondřej $u aInstitute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University bCentre of Outpatient Gynaecology and Primary Care, Brno cInstitute of Health Information and Statistics dInstitute of Pathology, 1st Faculty of Medicine, Charles University eCGOP, Prague, Czech Republic fFinnish Cancer Registry, Helsinki, Finland.
245    10
$a Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic / $c O. Májek, J. Dušková, V. Dvořák, A. Beková, D. Klimeš, M. Blaha, A. Anttila, L. Dušek,
520    9_
$a In 2008, the organized Czech National Cervical Cancer Screening Programme (CNCCSP) was initiated by transformation of the existing opportunistic efforts. The aim of our study was to examine recent cervical cancer burden trends and to assess the quality of the Czech National Cervical Cancer Screening Programme using a set of standard performance indicators. Our study utilized data from the national Cervical Cancer Screening Registry and the Czech National Cancer Registry. We computed internationally accepted indicators and assessed time trends and variability among screening centres. Between 1995 and 2011, the incidence of age-standardized cervical cancer decreased by 21% (1023 cases in 2011), and the mortality decreased by 35% (399 deaths in 2011). The annual coverage of the target population by cervical screening increased to 56% in 2013 (as compared with 35% in 2001). If we consider a 2-year interval (2012-2013), the estimated coverage was 77%. Over two million women underwent screening in 2013; 96% of them had a negative result. About 0.2% of smears showed cytological signs of a high-grade intraepithelial lesion or a malignancy, and the estimated positive predictive value for advanced intraepithelial neoplasia (cervical intraepithelial neoplasia grade 2+) was 79.6%. However, performance indicators show considerable heterogeneity between screening centres. The reported values of performance indicators are in line with the results of programmes that have previously been shown to be successful in terms of decreasing the cervical cancer burden, and are promising with respect to an even more pronounced decrease in cervical cancer mortality in the near future, provided that continuous quality improvement can be maintained. Linkage studies between screening, cancer and cause-of-death registers can provide further information on screening effectiveness and validity issues.
650    _2
$a dospělí $7 D000328
650    _2
$a Česká republika $x epidemiologie $7 D018153
650    _2
$a časná detekce nádoru $x metody $x trendy $7 D055088
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    12
$a registrace $7 D012042
650    _2
$a nádory děložního čípku $x diagnóza $x epidemiologie $7 D002583
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dušková, Jaroslava
700    1_
$a Dvořák, Vladimír, $d 1961- $7 xx0062700
700    1_
$a Beková, Alena
700    1_
$a Klimeš, Daniel
700    1_
$a Blaha, Milan
700    1_
$a Anttila, Ahti
700    1_
$a Dušek, Ladislav
773    0_
$w MED00001604 $t European journal of cancer prevention $x 1473-5709 $g Roč. 26, č. 3 (2017), s. 232-239
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26908155 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20240828141759 $b ABA008
999    __
$a ok $b bmc $g 1288772 $s 1008099
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 26 $c 3 $d 232-239 $i 1473-5709 $m European journal of cancer prevention $n Eur J Cancer Prev $x MED00001604
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace